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Abstract
Background:  High triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C)
jointly increase coronary disease risk. We performed linkage analysis for TG/HDL-C ratio in the
Framingham Heart Study data as a quantitative trait, using methods implemented in LINKAGE,
GENEHUNTER (GH), MCLINK, and SOLAR. Results were compared to each other and to those
from a previous evaluation using SOLAR for TG/HDL-C ratio on this sample. We also investigated
linked pedigrees in each region using by-pedigree analysis.
Results: Fourteen regions with at least suggestive linkage evidence were identified, including some
that may increase and some that may decrease coronary risk. Ten of the 14 regions were identified
by more than one analysis, and several of these regions were not previously detected. The best
regions identified for each method were on chromosomes 2 (LOD = 2.29, MCLINK), 5 (LOD =
2.65, GH), 7 (LOD = 2.67, SOLAR), and 22 (LOD = 3.37, LINKAGE). By-pedigree multi-point LOD
values in MCLINK showed linked pedigrees for all five regions, ranging from 3 linked pedigrees
(chromosome 5) to 14 linked pedigrees (chromosome 7), and suggested localizations of between
9 cM and 27 cM in size.
Conclusion: Reasonable concordance was found across analysis methods. No single method
identified all regions, either by full sample LOD or with by-pedigree analysis. Concordance across
methods appeared better at the pedigree level, with many regions showing by-pedigree support in
MCLINK when no evidence was observed in the full sample. Thus, investigating by-pedigree linkage
evidence may provide a useful tool for evaluating linkage regions.
Background
Obesity, diabetes, and hypertension are closely associated
with low levels of high-density lipoprotein cholesterol
(HDL-C) and elevated levels of triglycerides (TG), and are
recognized as jointly increasing coronary risk [1]. These
factors are the major components of the metabolic syn-
drome as outlined in the report of the National Choles-
terol Education Program's Adult Treatment Panel (ATP)
III [2].
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In an evaluation of a genetic component of the metabolic
syndrome, Shearman et al. [3] reported a genome-wide
scan for loci linked to TG/HDL-C ratio using Framingham
Heart Study (FHS) family data and SOLAR [4], which per-
forms variance-components analysis. SOLAR allows for
pedigrees of arbitrary size by estimating multi-point iden-
tity by descent (IBD) probabilities from the exact two-
point IBDs, which are then used in variance components
linkage statistic calculations. SOLAR assumes multivariate
normality, but is considered model-free and relies on little
prior knowledge of the underlying genetic model.
In contrast, parametric linkage analysis requires specifica-
tion of the underlying model of genetic inheritance. These
models are usually unknown and must be estimated.
Commingling analysis can be used to estimate genetic
parameters from the phenotypic data. Although paramet-
ric analysis requires model specification, it can provide
statistical power beyond that of model-free analyses [5].
Three linkage software packages able to perform paramet-
ric analyses include LINKAGE [6], GENEHUNTER [7],
and MCLINK [8].
LINKAGE calculates exact two-point IBD probabilities for
use in two-point linkage analysis, and can be used for ped-
igrees of arbitrary size. Two-point analysis is less sensitive
to misspecification of the model parameters than multi-
point, since these are absorbed into the maximization
over the recombination fraction, θ. For a detailed descrip-
tion see Göring and Terwilliger [9]. Two-point analysis,
however, can be sensitive to false positives, due to mis-
specification of marker allele frequencies or rare alleles
segregating in some families, or have low power, due to
poor IBD probability estimates.
Parametric analysis in GENEHUNTER (GH) also is an
exact likelihood method. Multi-point LOD analysis that is
less sensitive to inaccurate allele frequencies and is supe-
rior at determining IBD probabilities can be calculated;
however, multi-point LOD statistics are constrained for θ
= 0 and thus can be prone to false-negative results (loss of
power) if the model parameters are misspecified. Further,
the pedigree size capacity for GH is limited and with large
pedigrees can require extensive trimming, which can lead
to loss in power due to the elimination of important gene-
alogical and segregational information.
MCLINK is a Markov chain Monte Carlo (MCMC)
method that uses blocked Gibbs sampling to estimate
multi-point IBD probabilities on extended pedigree struc-
tures. In addition, MCLINK supports a robust multi-point
theta-LOD (TLOD) statistic [9,10]. The TLOD is a hybrid-
multi-point statistic that uses multi-point IBD probabili-
ties estimated from all available marker data, but calcu-
lates the LOD statistic under a two-point paradigm, thus
combining the benefits of the two-point analysis without
losing haplotype information.
Thus, while multi-point analysis methods have become
popular, exact multi-point methods cannot evaluate large,
extended pedigrees as exact two-point methods can. Esti-
mation methods may circumvent these issues, but may
have their own weaknesses. The major objective of this
study was to compare the linkage analysis results of LINK-
AGE, GH, and SOLAR to a potentially more robust para-
metric method, MCLINK, that incorporates all available
pedigree information into the linkage analysis.
Methods
Phenotype
The data for this study consisted of real FHS data for both
the original and offspring cohorts, as provided in Problem
1 of the Genetic Analysis Workshop 13 (GAW13) data set.
As noted by Shearman et al. [3], cholesterol measure-
ments were made on 12–14 h fasting blood samples. TG
concentrations were measured only once for FHS original
cohort participants, at Exams 10, 11, or 12. HDL choles-
terol measurements from the same exam as these TG lev-
els were used to compute the TG/HDL-C ratio. For the
offspring cohort, TG and HDL-C were measured at each of
the first five study cycles. The TG/HDL-C ratio was calcu-
lated for each of these cycles and the lowest ratio was
selected as the one to be used in the study. The rationale
was that the lowest value would generally represent meas-
urements that were less encumbered by environmental
factors. Because cholesterol values tend to become more
extreme with age, this process resulted in essentially all
TG/HDL-C values being drawn from offspring study cycle
1 or 2; thus the time frame of the cholesterol measure-
ments was the early 1970s for both original and offspring
cohorts. The TG/HDL-C ratio was normalized using the
natural logarithm to reduce skewing of the distribution.
Prior to linkage analysis, the TG/HDL-C ratio was
adjusted by regression for age, body mass index (BMI),
systolic blood pressure (SBP), and glucose level because of
the definition of the metabolic syndrome in the ATP III
guidelines [2], with BMI serving as an obesity-related sur-
rogate for waist circumference. The same or nearest exam
for which these measures were available was used in the
analyses. The regression residuals were taken to represent
the TG/HDL-C ratio free from the effects of the other fac-
tors (correlation of TG/HDL-C and these residuals was r =
0.80). Adjustment for smoking and alcohol was not used
because they are not components of the metabolic syn-
drome and they had essentially no effect on the TG/HDL-
C ratio (correlation of residuals before and after adjust-
ment for smoking and alcohol was very high, r = 0.996).
Physical activity and estrogen replacement therapy were
not available in the GAW13 FHS data set and thus couldBMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S93
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not be controlled as before [3]. Further, lipid-lowering
medication use was not available in the GAW13 data set.
Out of the 2885 FHS participants in the 330 available ped-
igrees of the genome scan, 2467 participants had an eval-
uable TG/HDL-C ratio and 2,461 had measured values for
all factors.
Genetic model
We used commingling analysis to determine genetic
parameters assuming normal distributions under a major
gene model. Commingling analysis revealed significant
evidence for two populations with mean TG/HDL-C resid-
uals of 1.26 and -0.08, with common standard deviation
0.56. Gene frequencies of 0.01 and 0.1 were used for the
dominant and recessive models. Four parametric models
(HighDom, HighRec, LowDom, and LowRec) were ana-
lyzed as we were interested in locating susceptibility genes
for both low (protective) and high (risk) TG/HDL-C
ratios. All LOD and TLOD scores were maximized over the
proportion of families linked using heterogeneity LODs
(α).
By-pedigree support
We used by-pedigree classical multi-point LOD statistics
(with θ = 0) available from MCLINK to assess if a pedigree
was linked to a region. Each region was defined as the 20
cM surrounding the peak full sample LOD. A pedigree was
considered linked to that region if a pedigree LOD > 0.588
was observed, which corresponds to a nominal p-value of
0.05. The region size was estimated using the 1-LOD drop
from the peak of the summed pedigree LODs (sumLOD)
for linked pedigrees only, and also from the observed
recombinants. We used the pedigree multi-point graphs
to estimate positions of recombinants, and used a drop of
0.5 LOD units to indicate the existence of a recombinant.
Results
Full sample linkage analyses
General characteristics of the study population are given
in Table 1. Overall, 14 regions were found to have at least
suggestive linkage with LOD scores above 1.9 [11] by at
least one analysis (Table 2).
Table 1: Population characteristics for the GAW13 FHS Cohorts.
Characteristic Overall Original Offspring
Age (years) 46.0 ± 14.8 59.8 ± 7.4 39.4 ± 12.7
Sex (male) 48.5% 46.7% 49.4%
TG/HDL-C ratio 1.8 ± 2.0 3.0 ± 2.7 1.3 ± 1.2
Systolic blood pressure (mm Hg) 126 ± 20 138 ± 21 120 ± 16
Body mass index (kg/m2) 26 ± 4 27 ± 4 25 ± 4
Glucose (mg/dL) 98 ± 22 98 ± 30 98 ± 16
Table 2: Regions with at least suggestive evidence under one analysis.A
Chr cM Nearest Marker LINKAGE GH MCLINKB SOLARC
1 276 203yg9 -D - 1.93 (276 cM, HD) -
2 201–05 GATA65C03 1.26 (205 cM, lr) - 2.29 (201 cM, lr) -
3 135–41 GATA84B12 - - 1.74 (135 cM, HD) 1.89 (m;141 cM)
2.50 (2;135 cM)
3 194 GATA3H01 1.95 (195 cM, Hr) - 1.98 (194 cM, Hr) -
5 103 GATA69H12 - 2.34 (103 cM, HD) 1.51 (103 cM, HD) -
5 125 ATA4D10 1.45 (125 cM, HD) 2.65 (125 cM, HD) 1.57 (125 cM, HD) -
7 48–57 GATA13G11 - 1.97 (52 cM, HD) - -
7 161–69 GATA32C12 - 1.52 (161 cM, Hr) 1.17 (156 cM, HD) 2.12 (m;169 cM)
2.67 (2;163 cM)
8 176 UT721 - 2.26 (176 cM, lr) - -
10 32–33 ATA31G11 1.82 (32 cM, lD) - 1.94 (33 cM, lr) -
13 36 GATA86H01 2.12 (36 cM, lD) - - -
17 126–29 044xg3 1.12 (128 cM, lr) 2.10 (129 cM, lr) 1.44 (126 cM, lr) 1.13 (2;127 cM)
19 0–11 GATA44F10 1.63 (11 cM, lD) 2.07 (0 cM, lD) 1.61 (0 cM, lD) -
22 21 Mfd313 3.37 (21 cM, lr) - - 1.28 (2; 21 cM)
AA region is reported only when at least one analysis produced a score over 1.9. In those regions all other analyses that reached at least a score 
>1.0 are also reported. BH, loci linked to high TG/HDL ratio; l, low TG/HDL-C ratio; D, dominant model; r, recessive model. CBoth two- and multi-
point variance component analyses were performed in SOLAR (2 indicates two-point, m indicates multipoint results). DIndicates no score above 
1.0.BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S93
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For the parametric analyses, regions were identified under
both the high and low TG/HDL-C ratio models. Analyses
evaluating potential loci predisposing to a high TG/HDL-
C ratio identified five potential regions on chromosomes
1, 3, 5, and 7 (Table 2). The highest scores (2.34 and 2.65)
were on chromosome 5 at 103 cM and 125 cM, both iden-
tified using GH with a dominant model. The locus at 125
cM was located by all three parametric methods, the sec-
ond, at 103 cM, was also located using MCLINK.
Parametric analyses to locate predisposition loci for low
TG/HDL-C ratio, which could indicate a genetically pro-
tective effect, identified seven regions on chromosomes 2,
8, 10, 13, 17, 19, and 22 (Table 2). The best two-point
score from LINKAGE was 3.37 on chromosome 22 (21
cM, recessive model). This locus was not located by other
parametric methods, but was identified by SOLAR two-
point analysis. The highest multi-point score was 2.29 on
chromosome 2 (210–17 cM, recessive model) and was
identified by MCLINK. This locus was also located by
LINKAGE (1.26 at 205 cM).
Model-free variance components analysis identified two
further regions on chromosomes 3 and 7 (Table 2). These
regions were both also located by MCLINK, and GH
located the region on chromosome 7 at approximately
160 cM.
By-pedigree linkage evidence
We followed up the best regions for each analysis method
on chromosomes 2 (201 cM, MCLINK), 5 (125 cM, GH),
7 (163 cM, SOLAR), and 22 (21 cM, LINKAGE) using
multi-point by-pedigree support as provided by MCLINK.
Despite using only MCLINK to identify linked pedigrees,
at least three linked pedigrees (LOD > 0.588) were found
for each region. For each of the regions analyzed, no con-
flicting recombinants were evident. Table 3 illustrates the
characteristics of the regions, including the number of
linked pedigrees found for each region, the peak sumLOD
(sum of the multi-point LODs for the linked pedigrees)
and the region size and boundaries both as estimated by
the 1-LOD drop and from inspection of estimated recom-
binants; in addition, the number of pedigrees that define
the left and right recombinant boundaries are given. The
smallest region (9 cM) was on chromosome 7, using
recombinant boundaries, however only one recombinant
on each side defined this region. The best recombinant
evidence was for the region on chromosome 2 where five
recombinants (two on the left hand side and three on the
right) defined an 18-cM region. In addition, this region
obtained the highest sumLOD (7.23), although this
defined the largest 1-LOD drop (21 cM).
Conclusions
Several loci were found by multiple analysis methods,
including a region on chromosome 17 identified by all
methods. This is reassuring, although a large range of
LODs was often seen for the same locus. Across all 14
regions identified, only four loci were identified using
only a single analysis method (one LINKAGE, two GH,
and one MCLINK), six regions were identified with two
methods, three regions were identified with three meth-
ods, and one region on chromosome 17 at 126–129 cM
was located by all four methods, although only GH iden-
tified the region with at least suggestive evidence. This
region on chromosome 17 was also the best region
observed by Klos et al. [12] for a related total cholesterol/
HDL ratio phenotype (LOD: 2.48), although Klos et al.
did not have any other TG- or HDL-C-related phenotypes
with LOD > 1.9.
In the analyses here, no single method identified all the
regions. MCLINK performed the best in this regard with
LODs > 1.0 in 10 of the total 14 regions, and 3 of the 4
regions missed were those identified by only a single
method.
Shearman et al. [3], using SOLAR to analyze a related TG/
HDL-C ratio phenotype, reported one region with sugges-
tive evidence for linkage on chromosome 7 at 155 cM
Table 3: Regions with at least suggestive evidence under one analysis.A
LINKAGE GH MCLINK SOLAR
Chromosome 22 5 2 7
Full Sample LOD 3.37 (2pt) 2.65 (mpt) 2.29 (mpt) 2.67 (2pt)
cM 21 cM 125 cM 201 cM 163 cM
No. peds linked 9 3 11 5
sumLOD 6.28 (mpt) 3.16 (mpt) 7.23 (mpt) 3.01 (mpt)
1-LOD size 13 cM 15 cM 21 cM 15 cM
1-LOD boundaries 12–25 cM 117–132 cM 192–213 cM 162–177 cM
Recomb size 27 cM 13 cM 18 cM 9 cM
Recomb boundaries 0–27 cM 114–127 cM 201–219 cM 161–170 cM
No. peds (L,R bnds) (0, 3) (1, 1) (2, 3) (1, 1)BMC Genetics 2003, 4 http://www.biomedcentral.com/1471-2156/4/s1/S93
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(LOD = 2.5), and a further four regions with LOD > 1.0 on
chromosomes 3 (LOD 1.8 at 140 cM), 11 (LOD 1.1 at 125
cM), 16 (LOD 1.1 at 75 cM), and 20 (LOD 1.7 at 35 cM).
Our SOLAR results similarly identified regions on chro-
mosomes 3 and 7 with comparable magnitude (Table 2).
In general, better agreement was found in this study
between the parametric methods than with the results
from SOLAR, and in particular between LINKAGE and
MCLINK. This may be due to the similarity in pedigree
structures analyzed. In addition, MCLINK agreed better
with GH than it did LINKAGE. The better agreement of
GH with MCLINK may be due to the multi-point nature
of both analyses. Further, MCLINK obtained better agree-
ment with SOLAR than the other two parametric meth-
ods. However, our model-free SOLAR results were more
concordant with those of Shearman et al. [3] than with the
parametric findings.
Even if a much less stringent LOD threshold were
imposed on the analyses of these data, no single method
used in this study would have identified all 14 regions
here. MCLINK identified only moderate-size peaks com-
pared across parametric methods, but located evidence for
linkage (LOD > 1.0) for 10 of the total 14 regions, and had
the best concordance with each of the other methods,
LINKAGE located 8 out of 14 regions, GH 7 out of the
total 14, and SOLAR only 4. Of the 7 locations it found,
GH found them all with LOD > 1.5. The lower number
located by GH may be partly due to loss of pedigree
structure.
The best four regions identified by each method were fol-
lowed up with by-pedigree analysis using MCLINK multi-
point LODs. Despite the lack of highly confirmatory full
sample scores, the by-pedigree support identified at each
locus was good (at least three pedigrees linked to each
region). This may indicate better consistency of LOD find-
ings at the pedigree level.
Other evaluations of linkage for TG and HDL-C pheno-
types have been published, in addition to those of Shear-
man et al. [3] and Klos et al. [12] that are mentioned
above, although only Shearman et al. have addressed the
ratio of TG/HDL-C. This study replicated a finding by Pea-
cock et al. [13] for HDL-C on chromosome 13 at 27.54 cM
(LOD: 2.36), although it did not replicate their other sug-
gestive finding on chromosome 5 (39.89 cM, LOD: 3.64).
Pajunkanta et al. [14] reported a region on chromosome
2 at 186 cM for TG among Finnish families, but their other
region on chromosome 10 was not replicated by this
study. Among that Finnish population, Soro et al. [15]
later reported on HDL-C, but none of their regions coin-
cided with the current study's findings. A study of both
HDL-C and TG as separate measures by Coon et al. [16]
also had no coincident findings.
The generally poor concordance between this study's find-
ings and the results of studies other than Shearman et al.
[3] may be due to the use of the ratio of TG and HDL-C,
which is regarded as a marker of insulin resistance or the
metabolic syndrome, and not just elevated cholesterol.
The current study evaluated a larger population with more
families than most other studies, though, and also exam-
ined loci for low TG/HDL-C ratio as a potentially protec-
tive factor, whereas other studies have only addressed loci
linked to increased risk lipids (elevated TG or reduced
HDL-C).
This study has identified loci linked to TG/HDL-C ratio
that may relate to the metabolic syndrome or insulin
resistance, including some that may increase coronary risk
and some that decrease risk. Further, it indicates that
multi-point and two-point analyses, based on exact inher-
itance probabilities (LINKAGE, GH) and estimation
methods (SOLAR, MCLINK) IBD, and parametric (LINK-
AGE, GH, MCLINK) and model-free (SOLAR) analyses
can all contribute to the identification of loci for complex
quantitative traits. Although we attempted no formal
comparison using simulations that would enable defini-
tive conclusions about the comparison of methods, these
results do provide a valuable practical comparison of
approaches. We found reasonable consistency across mul-
tiple methods, and suggest that consistency of findings, in
addition to LOD peak size, could be used in identifying
potential regions. Our results indicate that the MCMC
method, MCLINK, behaves as one might expect for a
method that has parallels with both two-point full pedi-
gree analyses and limited pedigree structure multi-point
analyses, with reasonable correspondence with both
methods. Our results further suggest the utility of inspect-
ing by-pedigree support for regions, both to increase con-
fidence and to increase region definition and narrowing.
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